The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
This article has 11 authors:Reviewed by ScreenIT
-
SARS-CoV-2 BNT162b2 vaccine–induced humoral response and reactogenicity in individuals with prior COVID-19 disease
This article has 10 authors:Reviewed by ScreenIT
-
Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans
This article has 9 authors:Reviewed by ScreenIT
-
Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic
This article has 6 authors:Reviewed by ScreenIT
-
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers
This article has 21 authors:Reviewed by ScreenIT
-
Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation
This article has 4 authors:Reviewed by ScreenIT
-
Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19
This article has 40 authors:Reviewed by ScreenIT
-
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
This article has 11 authors:Reviewed by ScreenIT
-
Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine?
This article has 10 authors:Reviewed by ScreenIT
-
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
This article has 20 authors:Reviewed by ScreenIT